Mode
Text Size
Log in / Sign up
Phase 3 N=78 Randomized Double-blind Treatment

ESP Block VS TAP in Laparoscopic Hysterectomy

Hysterectomy

Enrolled (actual)
78
Serious AEs
0.0%
Results posted
Jul 2022
Primary outcome: Primary: Visual Analogue Scale (VAS) Pain Scores at Rest at 1 Hour. — 2.8; 3 score on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Liposomal bupivacaine (Drug); bupivacaine, 0.125% (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Indiana University
Primary completion
Mar 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Analogue Scale (VAS) Pain Scores at Rest at 1 Hour.
2.8; 3
PRIMARY
Visual Analogue Scale (VAS) Pain Scores at Rest at 24 Hours.
3; 2.8
PRIMARY
Visual Analogue Scale (VAS) Pain Scores at Rest at 48 Hours.
2.1; 2
PRIMARY
Visual Analogue Scale (VAS) Pain Scores With Movement at 1 Hour.
3; 3.5
PRIMARY
Visual Analogue Scale (VAS) Pain Scores With Movement at 24 Hours.
4.3; 4.1
PRIMARY
Visual Analogue Scale (VAS) Pain Scores With Movement at 48 Hours.
3.4; 3.2
SECONDARY
Patient Sedation Score at 1 Hour
15; 15; 23; 24
SECONDARY
Patient Sedation Score at 24 Hours
2; 1; 34; 38
SECONDARY
Patient Sedation Score at 48 Hours
0; 1; 35; 38
SECONDARY
Patient Nausea Score at 1 Hour
5; 6; 33; 33
SECONDARY
Patient Nausea Score at 24 Hour
11; 7; 25; 32
SECONDARY
Patient Nausea Score at 48 Hour
2; 7; 33; 32
SECONDARY
Patient Satisfaction Score at 24 Hours
3.7; 3.6
SECONDARY
Patient Satisfaction Score at 48 Hours
3.7; 3.7

Summary

The purpose of this study is to compare the difference between two different pain control methods in patients who will be having a hysterectomy surgery. By collecting this data, we aim to show improved postoperative pain scores, decreased opioid needs, and decreased opioid side effects (nausea, sedation, ileus, urinary retention, respiratory depression).

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing laparoscopic hysterectomy surgery at Indiana University Hospital
  • ASA class 1, 2, 3 or 4
  • Age 18 or older, female
  • Desires Regional anesthesia for postoperative pain control

Exclusion Criteria

  • History of substance abuse in the past 6 months.
  • Patients on more than 30 mg morphine equivalents of opioids.
  • Any physical, mental or medical conditions which in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery.
  • Known allergy or other contraindications to the study medications (Acetaminophen, Gabapentin, Bupivacaine).
  • Postoperative intubation.
  • Any BMI greater than 40.0.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04003987). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search